Probiotics for cancer

Probiotics and prebiotics offer promising avenues in cancer research. Probiotics, live microorganisms that confer health benefits when consumed, exhibit potential in cancer prevention and treatment. They bolster gut health, which is linked to immune function and inflammation regulation—critical factors in cancer development. Additionally, probiotics may enhance chemotherapy efficacy and mitigate its side effects, like diarrhea and immune suppression. Prebiotics, indigestible fibers that nourish beneficial gut bacteria, complement probiotics by fostering their growth. This synergistic relationship forms a compelling strategy for cancer management. However, research must delve deeper into specific strains, doses, and timing to optimize their therapeutic potential. Harnessing the symbiotic power of probiotics and prebiotics holds promise in advancing cancer care, potentially revolutionizing treatment paradigms and improving patient outcomes.